Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.
The Biomarkers market is expected to be around US$ 113 billion by 2028 growing at around 13% CAGR. The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.
The biomarkers market is segmented by product, by type, by application and by disease indication. By product type it consists of consumable, services and software. By segmentation it covers safety biomarker, efficacy biomarker and validation biomarker. The efficacy biomarker is further segmented into pharmacodynamics, predictive, prognostic and surrogate biomarkers. The biomarkers have different applications such as diagnostics development, drug discovery & development, personalized medicine and disease risk assessment. Under disease indication it contains cancer, cardiovascular disorders, neurological disorders and immunological disorders. The biomarkers market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for biomarkers and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for biomarkers.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of biomarkers with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Biomarkers Market has been segmented as below:
By Product Segment Analysis
Consumable
Services
Software
By Type Analysis
Safety biomarker,
Efficacy biomarker
Validation biomarker
By Application Analysis
Diagnostics development
Drug discovery & development
Personalized medicine
Disease risk assessment
By Disease Indication Analysis
Cancer
Cardiovascular disorders
Neurological disorders
Immunological disorders
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all active and planned biomarkers industry globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of biomarkers industry and unit capacity data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
urinary tract infection treatment market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.3 Market Rank Estimation
2.4 Key Industry Insights
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Biomarkers: Market Overview
4.2 Geographic Analysis: Biomarkers Market, By Product (2017)
4.3 Market, By Type, 2017 vs 2023
4.4 Market Size, By Application, 2017 vs 2023
4.5 Market, By Disease Indication, 2017 vs 2023
4.6 Market: Geographic Growth Opportunities
4.7 Life Cycle Analysis, By Region, 2017
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Diagnostic Applications of Biomarkers
5.2.1.1.1 Personalized Medicine
5.2.1.1.2 Companion Diagnostics
5.2.1.2 Increasing R&D Funding for Pharma and Biotech Companies
5.2.1.3 Increasing Number of Cros and Low Cost of Clinical Trials in Developing Countries
5.2.1.4 High Prevalence of Cancer
5.2.1.5 New Initiatives for Biomarker Research
5.2.2 Restraints
5.2.2.1 High Capital Investments and Low Cost-Benefit Ratio
5.2.2.2 Poorly Suited Regulatory and Reimbursement Systems
5.2.2.3 Technical Issues Related to Sample Collection and Storage
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.4 Challenges
5.2.4.1 Proving the Clinical Validity in Biomarker-Based Tests
6 Biomarkers Market, By Product
6.1 Introduction
6.2 Consumables
6.3 Services
6.4 Software
7 Biomarkers Market, By Type
7.1 Introduction
7.2 Safety Biomarkers
7.3 Efficacy Biomarkers
7.3.1 Predictive Biomarkers
7.3.2 Surrogate Biomarkers
7.3.3 Pharmacodynamic Biomarkers
7.3.4 Prognostic Biomarkers
7.4 Validation Biomarkers
8 Biomarkers Market, By Application
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery and Development
8.4 Personalized Medicine
8.5 Disease Risk Assessment
8.6 Other Applications
9 Biomarkers Market, By Disease Indication
9.1 Introduction
9.2 Cancer
9.3 Cardiovascular Disorders
9.4 Neurological Disorders
9.5 Immunological Disorders
9.6 Other Diseases
10 Biomarkers Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 Rest of Asia
10.5 Rest of the World (RoW)
11 Competitive Landscape
11.1 Overview
11.2 Competitive Situation and Trends
11.2.1 Product Launches
11.2.2 Collaborations, Partnerships, and Agreements
11.2.3 Acquisitions
11.2.4 Other Developments
11.3 Leading Players in the Biomarkers Market
12 Company Profiles
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.
The Biomarkers Market has been segmented as below:
By Product Segment Analysis
Consumable
Services
Software
By Type Analysis
Safety biomarker,
Efficacy biomarker
Validation biomarker
By Application Analysis
Diagnostics development
Drug discovery & development
Personalized medicine
Disease risk assessment
By Disease Indication Analysis
Cancer
Cardiovascular disorders
Neurological disorders
Immunological disorders
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
